# CART-19 for Multiple Myeloma

> **NCT02135406** · PHASE1 · COMPLETED · sponsor: **University of Pennsylvania** · enrollment: 13 (actual)

## Conditions studied

- Multiple Myeloma

## Interventions

- **BIOLOGICAL:** CART-19 T cells

## Key facts

- **NCT ID:** NCT02135406
- **Lead sponsor:** University of Pennsylvania
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-05
- **Primary completion:** 2015-09
- **Final completion:** 2018-01-18
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-06-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02135406

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02135406, "CART-19 for Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02135406. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*